Bawneet K Narang Selected Research

Enzymes

1/2014

A novel integrase targeting agent to explore the future prospective of HIV eradication: dolutegravir.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bawneet K Narang Research Topics

Disease

1	medullary Thyroid cancer 01/2015
1	Pulmonary Arterial Hypertension 01/2015
1	Breast Neoplasms (Breast Cancer) 01/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2015
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2015
1	Melanoma (Melanoma, Malignant) 01/2015
1	Neoplasms (Cancer) 01/2015
1	Ovarian Neoplasms (Ovarian Cancer) 01/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2014
1	Infections 01/2014

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2015 - 01/2014
1	riociguatIBA 01/2015
1	cabozantinibIBA 01/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2015
1	Proto-Oncogene Proteins c-metIBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	EnzymesIBA 01/2014
1	Human immunodeficiency virus 1 p31 integrase proteinIBA 01/2014
1	HIV IntegraseIBA 01/2014

Therapy/Procedure

1	Castration 01/2015
1	Therapeutics 01/2015